Columbia scientists have developed a new computational framework that can support precision cancer treatment by matching individual tumors with the drugs most likely to kill them.
A study has found 18 new genes that drive an aggressive form of brain cancer, doubling the number of known driver genes of glioblastoma.
Key molecular pathways that lead to Alzheimer's identified—a new approach to Alzheimer’s research; several potential drug targets highlighted.
Researchers in the new Department of Systems Biology reverse engineer tumors to tailor cancer therapy to the individual patient.
New computational tool translates complex data into 2-dimensional images; may allow doctors to track cancer progression.
A massive study analyzing gene expression data from 22 tumor types has identified multiple metabolic expression changes associated with cancer.